Top

Published in:

01-05-2012 | Original Article

Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study

Authors: Franco Cozzi, Giancarlo Parisi, Luca Ciprian, Arianna Bullo, Silvia Cardarelli, Michela Rizzo, Paolo Sfriso, Leonardo Punzi

Published in: Rheumatology International | Issue 5/2012

Abstract

Gastric involvement appears quite commonly in systemic sclerosis (SSc). The aim of this study was to evaluate gastric wall motility using ultrasonography, a noninvasive method able to track both filling and emptying of fundus and antrum. The study was performed in 20 SSc patients and 20 healthy control subjects. Gastric filling and emptying were evaluated by transabdominal ultrasonography, measuring changes in fundus and antral areas over a 1-h period after ingestion of a liquid bolus (500 ml of mineral water). Areas of both gastric fundus and antrum at basal evaluation were found to be smaller in SSc patients than in healthy controls. Gastric filling was significantly reduced after ingestion of liquid bolus. Gastric emptying was delayed both in fundus and antrum. No significant differences of gastric wall motility have been observed in different subsets of SSc patients. Our findings show that gastric dysmotility is frequent and severe in SSc patients, contributing to the gastrointestinal disturbances which are very common in this disease.

Lock G, Holstege A, Lang B, Scholmerich J (1997) Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 92:763–771PubMed

Weston S, Thumshirn M, Wiste J, Camilleri M (1998) Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 93:1085–1089PubMedCrossRef

Attar A (2002) Atteintes digestives au cours de la sclérodermie. Ann Med Interne 153:260–264

Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A (2003) Assessment of gastrointestinal involvement. Clin Exp Rheumatol 21(Suppl 29):S15–S18PubMed

Forbes A, Marie I (2009) Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology 48(Suppl 3):36–39

D’Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428–440PubMedCrossRef

Sjogren RW (1994) Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37:1265–1282PubMedCrossRef

Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39:2209–2215PubMedCrossRef

Garrett JM, Winkelmann RK, Schlegel JF, Code CF (1971) Esophageal deterioration in scleroderma. Mayo Clin Proc 46:92–96PubMed

10.

Bassotti G, Battaglia E, Debernardi V, Germani U, Quiriconi F, Dughera L et al (1997) Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 40:2252–2259PubMedCrossRef

11.

Cozzi F, Zucchetta P, Durigon N, Marzola MC, Bullo A, Favaro M et al (2003) Alterazioni della peristalsi esofagea nelle diverse forme cliniche e specificità anticorpali della sclerodermia: studio scintigrafico in 100 pazienti. Reumatismo 55:86–92PubMed

12.

Abu-Shakra M, Guillemin F, Lee P (1994) Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum 24:29–39PubMedCrossRef

13.

Zamost BJ, Hirschberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM (1987) Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology 92:421–428PubMed

14.

Maddern GJ, Horowitz M, Jamieson GG, Chatterton BE, Collins PJ, Roberts-Thomson P (1984) Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 87:922–926PubMed

15.

Greydanus MP, Camilleri M (1989) Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 96:110–115PubMed

16.

Marie I, Levesque H, Ducrotte P, Denis P, Benichou J, Hellot MF et al (1998) Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study. Arthritis Rheum 41:1874–1883PubMedCrossRef

17.

Battle WM, Snape WJ Jr, Wright S, Sullivan MA, Cohen S, Meyers A et al (1981) Abnormal colonic motility in progressive systemic sclerosis. Ann Intern Med 94:749–752PubMed

18.

Wang SJ, Lan JL, Chen DY, Chen YH, Hsieh TY, Lin WY (2001) Colonic transit disorders in systemic sclerosis. Clin Rheumatol 20:251–254PubMedCrossRef

19.

Leighton JA, Valdovinos MA, Pemberton JH, Rath DM, Camilleri M (1993) Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 36:182–185PubMedCrossRef

20.

Heyt GJ, Oh MK, Alemzadeh N, Rivera S, Jimenez SA, Rattan S et al (2004) Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence. Dig Dis Sci 49:1040–1045PubMedCrossRef

21.

Duan LP, Zheng ZT, Li YN (1993) A study of gastric emptying in non-ulcer dyspepsia using a new ultrasonographic method. Scand J Gastroenterol 28:355–360PubMedCrossRef

22.

Kusunoki H, Haruma K, Hata J, Tani H, Okamoto E, Sumii K et al (2000) Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol 15:1022–1027PubMedCrossRef

23.

Subcomittee for scleroderma criteria of the American Rheumatism Association Diagnostic, Theurapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef

24.

Le Roy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205

25.

Bolondi L, Bortolotti M, Santi V, Calletti T, Gaiani S, Labò G (1985) Measurement of gastric emptying time by real-time ultrasonography. Gastroenterology 89:752–759PubMed

26.

Marzio L, Giacobbe A, Conoscitore P, Facciorusso D, Frusciante V, Modoni S (1989) Evaluation of the use of ultrasonography in the study of liquid gastric emptying. Am J Gastroenterol 84:496–500PubMed

27.

Sallam H, McNearny TA, Chen DZ (2006) Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 23:691–712PubMedCrossRef

28.

Iovino P, Valentini G, Ciacci C, De Luca A, Tremolaterra F, Sabbatini F et al (2001) Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function. Dig Dis Sci 46:723–730PubMedCrossRef

29.

Bortolotti M, Turba E, Tosti A, Sarti P, Brunelli F, Del Campo L et al (1991) Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol 86:743–747PubMed

30.

Marycz T, Muehldorfer SM, Gruschwitz MS, Katalinic A, Herold C, Ell C et al (1999) Gastric involvement in progressive systemic sclerosis: electrogastrographic and sonographic findings. Eur J Gastroenterol Hepatol 11:1151–1156PubMedCrossRef

31.

Marie I, Levesque H, Ducrotte P, Denis P, Hellot MF, Benichou J et al (2001) Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 96:77–83PubMedCrossRef

32.

McNearney T, Lin X, Shrestha J, Lisse J, Chen JD (2002) Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography. Dig Dis Sci 47:690–698PubMedCrossRef

33.

Madsen JL, Hendel L (1992) Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis. Dig Dis Sci 37:1404–1408PubMedCrossRef

34.

Irvine EJ, Tougas G, Lappalainen R, Bathurst NC (1993) Reliability and interobserver variability of ultrasonographic measurement of gastric emptying rate. Dig Dis Sci 38:803–810PubMedCrossRef

35.

Hveem K, Jones KL, Chatterton BE, Horowitz M (1996) Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite. Gut 38:816–821PubMedCrossRef

36.

Wedmann B, Wegener M, Adamek RJ, Gammal S (1994) Gastrobiliary motility after liquid fatty meal in progressive systemic sclerosis. A sonographic study. Dig Dis Sci 39:565–570PubMedCrossRef

37.

Di Ciaula A, Covelli M, Bernardino M, Wang DQ, Lapadula G, Palasciano G et al (2008) Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol 27:8–17

38.

Manetti M, Neumann E, Milia AF, Tarner IH, Bechi P, Matucci-Cerinic M et al (2007) Severe fibrosis and increate expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum 56:3442–3447PubMedCrossRef

39.

Kahaleh MB, Matucci-Cerinic M (1995) Raynaud’s phenomenon, scleroderma dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 38:1–4PubMedCrossRef

40.

Kaye SA, Seifalian AM, Lim SG, Hamilton G, Black CM (1994) Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud’s phenomenon or chronic vasculopathy. Q J Med 87:495–500

41.

Bertinotti L, Bracci S, Nacci F, Colangelo N, Del Rosso A, Casale R et al (2004) The autonomic nervous system in systemic sclerosis. A review. Clin Rheumatol 23:1–5PubMedCrossRef

42.

Lock G, Straub RH, Zeuner M, Antoniou E, Holstege A, Scholmerich J et al (1998) Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J Rheumatol 25:1330–1335PubMed

43.

Ibba-Manneschi L, Del Rosso A, Pacini S, Tani A, Bechi P, Matucci Cerinic M (2002) Ultrastructural study of the muscle coat of the gastric wall in a case of systemic sclerosis. Ann Rheum Dis 61:754–756PubMedCrossRef

44.

Sogabe M, Okahisa T, Tsujigami K, Okita Y, Hayashi H, Taniki T et al (2005) Ultrasonographic assessment of gastric motility in diabetic gastroparesis before and after attaining glycemic control. J Gatroenterol 40:583–590CrossRef

45.

Szarka LA, Camilleri M (2010) Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology. J Diabetes Sci Technol 4:180–189PubMed

46.

Hata N, Murata S, Maeda J, Yatani H, Kohno Y, Yokono K, Okano H (2009) Predictors of gastric myoelectrical activity in type 2 diabetes mellitus. J Clin Gastroenterol 43:429–436PubMedCrossRef

47.

Franck-Larsson K, Hedenstrom H, Dahl R, Ronnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32:348–355PubMedCrossRef

Title: Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study
Authors: Franco Cozzi
Giancarlo Parisi
Luca Ciprian
Arianna Bullo
Silvia Cardarelli
Michela Rizzo
Paolo Sfriso
Leonardo Punzi
Publication date: 01-05-2012
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 5/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-010-1779-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2012

Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies

Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis

Association of the C-285T and A5954G polymorphisms in the DNA repair gene OGG1 with the susceptibility of rheumatoid arthritis

A convenient method for producing the bleomycin-induced mouse model of scleroderma by weekly injections using a methylcellulose gel

Pain intensity and quality of life perception in children with hypermobility syndrome

Involvement of soluble receptor activator of nuclear factor-κB ligand (sRANKL) in collagenase-induced murine osteoarthritis and human osteoarthritis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials